Denali Therapeutics is a leader in the biopharmaceutical industry, dedicated to developing effective therapies for neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. By leveraging advanced genetics and biomarker-driven drug discovery, the company focuses on targeting the underlying causes of degeneration to bring life-changing medicines to patients suffering from complex neurological conditions.
The company prides itself on a culture of scientific rigor and collaborative innovation. With a foundation built on the expertise of world-class scientists and visionary partners, Denali maintains an agile, mission-driven atmosphere. Employees are encouraged to push the boundaries of current biological understanding in an inclusive environment that values transparency and diversity of thought.